創薬技術：市場動向と2029年までの市場予測

Report Highlights

The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.

創薬技術の世界市場は、2024 年の 1,119 億ドルから成長し、2024 年から 2029 年の予測期間中に 12.0% の年間平均成長率 (CAGR) で、2029 年末までに 1,970 億ドルに達すると予測されています。

Report Scope:

This report provides detailed information on the drug discovery technologies market. This report analyzes the market trends of drug discovery technologies with data from 2023, estimates from 2024, projections of compound annual growth rates (CAGRs) through 2029 (forecast period 2024-2029), and regional markets of drug discovery technologies. This report highlights drug discovery technologies’ current and future market potential and gives a detailed analysis of the competitive environment. The report covers regulatory scenarios, drivers, restraints, and opportunities. This report also covers market projections for 2029 and the market share for key market players.

The market scope in this report is segmented into technologies and applications. Based on technologies, this report covers high-throughput screening (HTS), bioanalytical instruments, cell-based assays and reagents, genomics, bioinformatics, proteomics, and others, such as combinatorial chemistry, metabolomics, nanotechnology, and system biology. These technologies are further classified into subcategories for this report. The market is segmented based on application to oncology, cardiovascular diseases, neurodegenerative diseases, immunological diseases, and others.

The market has been segmented into North America, Europe, Asia-Pacific, and other world regions. The regional segment covers a detailed analysis of major countries such as the U.S., Canada, Germany, the U.K., Italy, Spain, France, Japan, China, South Korea, Australia, and India. For market estimates, data is provided for 2023, with forecasts for 2024 and projections for 2029.
The report’s goals include:
– Analyzing technologies and applications.
– Analyzing global market size and segmentation.
– Identifying market constraints and drivers.
– Providing detailed market forecasts through 2029.
– Assessing market shares, competitiveness, and industry structure.
– Identifying potential long-term impacts on the drug discovery technologies market.

Report Synopsis

Report Includes:

– 104 data tables and 34 additional tables
– An analysis of the current and future global markets for drug discovery technologies
– Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
– Estimates of the market size and revenue forecasts for the global market for drug discovery technologies, with market share analysis by therapeutics, application, end user and region
– Discussion of bioinformatics as a platform for drug discovery
– A comparison between proteomics and genomics drug discovery technology
– Comparative assessment of pharmacokinetics and pharmacodynamics, and classification of the techniques used in drug discovery
– Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
– Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes
– Competitive intelligence, including companies’ market shares, recent M&A activity and venture funding
– Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher Corp., Agilent Technologies Inc., Illumina, and Charles River Laboratories.

Executive Summary

Summary:

Drug development and drug discovery are crucial aspects of the pharmaceutical and biotechnology sectors, driven by applying advanced technologies such as proteomics, bioanalytical, computational, and HTS. These technologies enable a mechanistic approach to lead identification, drug delivery, validation, and targeting, leading to market expansion. As businesses focus on meeting customer demands, R&D spending, growing competition, patent expirations, and new technologies are driving the market, resulting in consistent income for forward-thinking pharmaceutical and biopharmaceutical firms.

Drug development technologies, including nanotechnology and cellular imaging, focus on early-stage screening methods to identify new leads and targets for drug development. The multibillion-dollar drug discovery technology market includes pharmaceutical and biomedical research, aiming to create high quality yet affordable medications. This includes genetic, cellular, proteomic, and systemic studies of the human body. Technology has advanced drug development, with automation, nanofluidic, imaging, software and test technologies enabling faster data acquisition and better drug candidate creation.

Technologies are being utilized in medication development to identify key lead chemicals for different cancer types. Research organizations and biopharmaceutical businesses are exploring molecular and biochemical issues to develop mechanistic techniques. Technologies like next-generation sequencing (NGS), proteomics, genomics, and HTS are being used for cellular investigation, focusing on developing mechanistic techniques for drug development.

The drug discovery industry is experiencing continued growth due to progress in biochemical, translational, and molecular studies in biomedical research. These technologies are commercially employed in the development of new and efficient drug candidates. The booming healthcare sector and increased government funding have also aided growth in this market. The delineation of mechanistic details and the underlying mechanisms of drug-target interaction have paved the way for more accurate and effective therapies.

Increasing numbers of chronic diseases are boosting the drug discovery technologies’ market growth. Chronic disease affects hundreds of millions of patients globally. According to the American Hospital Association, approximately 45% of Americans, or 133 million people, suffer from one or more chronic healthcare conditions. In Europe, nearly 60 million people have more than one chronic disease. Chronic disease prevalence is expected to rise rapidly in the forecast period (2024-2029), which is expected to create a significant burden on global healthcare.

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of the Report
Market Summary
Chapter 2 Market Overview
Overview
Porter’s Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
High-Content Screening (HCS) Techniques in Drug Discovery
Technological Advances
Demand for Personalized Medicine
Rising Prevalence of Chronic and Immunological Diseases
Growing Elderly Population
Availability of Research Funds
Market Restraints
Cost of the Drug Discovery Process and Instruments
Stringent Regulations
Better Understanding of Molecular Mechanisms
Market Opportunities
Potential for AI in Drug Discovery
Chapter 4 Emerging Technologies
Overview
AI
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Global Market for Drug Discovery Technologies, by Technology
Global Market Forecast
High-Throughput Screening (HTS)
Bioanalytical Instruments
Genomics
Proteomics
Cell-Based Assays and Reagents
Bioinformatics
Other Technologies
Market for Drug Discovery Technologies, by Disease Application
Global Market Size and Forecast
Oncology
Cardiology
Neurodegenerative Diseases
Immunological Diseases
Other Diseases
Global Market for Drug Discovery Technologies, by End User
Global Market Size and Forecast
Biopharmaceutical Companies
Research and Academia
Contract Research Organizations (CROs)
Geographic Breakdown
Global Market for Drug Discovery Technologies, by Region
Global Market Size and Forecast
North America
Europe
Asia-Pacific
Rest of World
Chapter 6 Competitive Intelligence
Competitive Landscape
Analysis of Companies’ Market Shares
SWOT Analysis
Strengths
Challenges
Opportunities
Threats
Chapter 7 Sustainability in the Drug Delivery Technologies Market: An ESG Perspective
Introduction to ESG
Sustainability in the Drug Discovery Technologies Industry
ESG Perspective
Environmental Impact
Social Impact
Governance Impact
Chapter 8 Appendix
Methodology
Abbreviations
Sources
Company Profiles
AGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.
BRUKER
CHARLES RIVER LABORATORIES
DANAHER CORP.
ILLUMINA INC.
PROMEGA CORP.
QIAGEN
REVVITY
THERMO FISHER SCIENTIFIC INC.

List of Tables

List of Tables
Summary Table : Global Market for Drug Discovery Technologies, by Technology, Through 2029
Table 1 : Porter’s Five Forces Analysis of the Drug Discovery Technologies Market
Table 2 : Global Diabetes Prevalence, Estimates and Projections, 2021–2045
Table 3 : Global Prevalence of Multiple Sclerosis, by WHO Region, 2013 and 2020
Table 4 : Global HIV Epidemic, by Age Group, 2023
Table 5 : Global Population Growth, by Age Group, Through 2050
Table 6 : Global Market for Drug Discovery Technologies, by Technology, Through 2029
Table 7 : Global Market for HTS in Drug Discovery, by Region, Through 2029
Table 8 : Global Market for Bioanalytical Instruments in Drug Discovery, by Product Type, Through 2029
Table 9 : Global Market for Bioanalytical Instruments in Drug Discovery, by Region, Through 2029
Table 10 : Global Market for Genomics in Drug Discovery, by Product Type, Through 2029
Table 11 : Global Market for Genomics in Drug Discovery, by Region, Through 2029
Table 12 : Protein Microarrays and Their Functions
Table 13 : Global Market for Proteomics in Drug Discovery, by Product Type, Through 2029
Table 14 : Global Market for Proteomics in Drug Discovery, by Region, Through 2029
Table 15 : Cell Biology Reagents and Their Functions
Table 16 : Global Market for Cell-Based Assays and Reagents in Drug Discovery, by Product Type, Through 2029
Table 17 : Global Market for Cell-based Assays and Reagents in Drug Discovery, by Region, Through 2029
Table 18 : Global Market for Bioinformatics in Drug Discovery, by Region, Through 2029
Table 19 : Comparison of Solid-Phase and Solution-Phase Synthesis
Table 20 : Global Market for Other Technologies in Drug Discovery, by Region, Through 2029
Table 21 : Global Market for Drug Discovery Technologies, by Application, Through 2029
Table 22 : Global Market for Drug Discovery Technologies in Oncology, by Region, Through 2029
Table 23 : Global Market for Drug Discovery Technologies in Cardiology, by Region, Through 2029
Table 24 : Global Market for Drug Discovery Technologies in Neurodegenerative Diseases, by Region, Through 2029
Table 25 : Global Market for Drug Discovery Technologies in Immunological Diseases, by Region, Through 2029
Table 26 : Global Market for Drug Discovery Technologies in Other Diseases, by Region, Through 2029
Table 27 : Global Market for Drug Discovery Technologies, by End User, Through 2029
Table 28 : Global Market for Drug Discovery Technologies in Biopharma Companies, by Region, Through 2029
Table 29 : Global Market for Drug Discovery Technologies in Research and Academia, by Region, Through 2029
Table 30 : Global Market for Drug Discovery Technologies in CROs, by Region, Through 2029
Table 31 : Global Market for Drug Discovery Technologies, by Region, Through 2029
Table 32 : North American Market for Drug Discovery Technologies, by Technology, Through 2029
Table 33 : North American Market for Drug Discovery Technologies, by Application, Through 2029
Table 34 : North American Market for Drug Discovery Technologies, by End User, Through 2029
Table 35 : North American Market for Drug Discovery Technologies, by Country, Through 2029
Table 36 : U.S. Market for Drug Discovery Technologies, by Technology, Through 2029
Table 37 : U.S. Market for Drug Discovery Technologies, by Application, Through 2029
Table 38 : U.S. Market for Drug Discovery Technologies, by End User, Through 2029
Table 39 : Canadian Market for Drug Discovery Technologies, by Technology, Through 2029
Table 40 : Canadian Market for Drug Discovery Technologies, by Application, Through 2029
Table 41 : Canadian Market for Drug Discovery Technologies, by End User, Through 2029
Table 42 : Mexican Market for Drug Discovery Technologies, by Technology, Through 2029
Table 43 : Mexican Market for Drug Discovery Technologies, by Application, Through 2029
Table 44 : Mexican Market for Drug Discovery Technologies, by End User, Through 2029
Table 45 : European Market for Drug Discovery Technologies, by Technology, Through 2029
Table 46 : European Market for Drug Discovery Technologies, by Application, Through 2029
Table 47 : European Market for Drug Discovery Technologies, by End User, Through 2029
Table 48 : European Market for Drug Discovery Technologies, by Country, Through 2029
Table 49 : German Market for Drug Discovery Technologies, by Technology, Through 2029
Table 50 : German Market for Drug Discovery Technologies, by Application, Through 2029
Table 51 : German Market for Drug Discovery Technologies, by End User, Through 2029
Table 52 : U.K. Market for Drug Discovery Technologies, by Technology, Through 2029
Table 53 : U.K. Market for Drug Discovery Technologies, by Application, Through 2029
Table 54 : U.K. Market for Drug Discovery Technologies, by End User, Through 2029
Table 55 : French Market for Drug Discovery Technologies, by Technology, Through 2029
Table 56 : French Market for Drug Discovery Technologies, by Application, Through 2029
Table 57 : French Market for Drug Discovery Technologies, by End User, Through 2029
Table 58 : Italian Market for Drug Discovery Technologies, by Technology, Through 2029
Table 59 : Italian Market for Drug Discovery Technologies, by Application, Through 2029
Table 60 : Italian Market for Drug Discovery Technologies, by End User, Through 2029
Table 61 : Spanish Market for Drug Discovery Technologies, by Technology, Through 2029
Table 62 : Spanish Market for Drug Discovery Technologies, by Application, Through 2029
Table 63 : Spanish Market for Drug Discovery Technologies, by End User, Through 2029
Table 64 : Rest of Europe Market for Drug Discovery Technologies, by Technology, Through 2029
Table 65 : Rest of Europe Market for Drug Discovery Technologies, by Application, Through 2029
Table 66 : Rest of Europe Market for Drug Discovery Technologies, by End User, Through 2029
Table 67 : Asia-Pacific Market for Drug Discovery Technologies, by Technology, Through 2029
Table 68 : Asia-Pacific Market for Drug Discovery Technologies, by Application, Through 2029
Table 69 : Asia-Pacific Market for Drug Discovery Technologies, by End User, Through 2029
Table 70 : Asia-Pacific Market for Drug Discovery Technologies, by Country, Through 2029
Table 71 : Chinese Market for Drug Discovery Technologies, by Technology, Through 2029
Table 72 : Chinese Market for Drug Discovery Technologies, by Application, Through 2029
Table 73 : Chinese Market for Drug Discovery Technologies, by End User, Through 2029
Table 74 : Japanese Market for Drug Discovery Technologies, by Technology, Through 2029
Table 75 : Japanese Market for Drug Discovery Technologies, by Application, Through 2029
Table 76 : Japanese Market for Drug Discovery Technologies, by End User, Through 2029
Table 77 : Indian Market for Drug Discovery Technologies, by Technology, Through 2029
Table 78 : Indian Market for Drug Discovery Technologies, by Application, Through 2029
Table 79 : Indian Market for Drug Discovery Technologies, by End User, Through 2029
Table 80 : South Korean Market for Drug Discovery Technologies, by Technology, Through 2029
Table 81 : South Korean Market for Drug Discovery Technologies, by Application, Through 2029
Table 82 : South Korean Market for Drug Discovery Technologies, by End User, Through 2029
Table 83 : Australian Market for Drug Discovery Technologies, by Technology, Through 2029
Table 84 : Australian Market for Drug Discovery Technologies, by Application, Through 2029
Table 85 : Australian Market for Drug Discovery Technologies, by End User, Through 2029
Table 86 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by Technology, Through 2029
Table 87 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by Application, Through 2029
Table 88 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by End User, Through 2029
Table 89 : RoW Market for Drug Discovery Technologies, by Technology, Through 2029
Table 90 : RoW Market for Drug Discovery Technologies, by Application, Through 2029
Table 91 : RoW Market for Drug Discovery Technologies, by End User, Through 2029
Table 92 : RoW Market for Drug Discovery Technologies, by Sub-Region, Through 2029
Table 93 : South American Market for Drug Discovery Technologies, by Technology, Through 2029
Table 94 : South American Market for Drug Discovery Technologies, by Application, Through 2029
Table 95 : South American Market for Drug Discovery Technologies, by End User, Through 2029
Table 96 : MEA Market for Drug Discovery Technologies, by Technology, Through 2029
Table 97 : MEA Market for Drug Discovery Technologies, by Application, Through 2029
Table 98 : MEA Market for Drug Discovery Technologies, by End User, Through 2029
Table 99 : Focus Areas in ESG Metrics
Table 100 : ESG Rankings for Drug Discovery Technologies, as of May 2024
Table 101 : Abbreviations Used in this Report
Table 102 : Report Sources
Table 103 : Agilent Technologies Inc.: Company Snapshot
Table 104 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 105 : Agilent Technologies Inc.: Product Portfolio
Table 106 : Agilent Technologies Inc.: News/Key Development, 2024
Table 107 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 108 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 109 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 110 : Bio-Rad Laboratories Inc.: News/Key Developments, 2024
Table 111 : Bruker: Company Snapshot
Table 112 : Bruker: Financial Performance, FY 2022 and 2023
Table 113 : Bruker: Product Portfolio
Table 114 : Bruker: News/Key Developments, 2024
Table 115 : Charles River Laboratories: Company Snapshot
Table 116 : Charles River Laboratories: Financial Performance, FY 2022 and 2023
Table 117 : Charles River Laboratories: Service Portfolio
Table 118 : Danaher Corp.: Company Snapshot
Table 119 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 120 : Danaher Corp.: Product Portfolio
Table 121 : Danaher Corp.: News/Key Developments, 2022
Table 122 : Illumina: Company Snapshot
Table 123 : Illumina: Financial Performance, FY 2022 and 2023
Table 124 : Illumina: Product Portfolio
Table 125 : Promega Corp.: Company Snapshot
Table 126 : Promega Corp.: Product Portfolio
Table 127 : Qiagen: Company Snapshot
Table 128 : Qiagen: Financial Performance, FY 2022 and 2023
Table 129 : Qiagen: Product Portfolio
Table 130 : Qiagen: News/Key Developments, 2024
Table 131 : Revvity: Company Snapshot
Table 132 : Revvity: Financial Performance, FY 2022 and 2023
Table 133 : Revvity: Product Portfolio
Table 134 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 135 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 136 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 137 : Thermo Fisher Scientific Inc.: News/Key Developments, 2024

List of Figures

List of Figures
Summary Figure : Global Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 1 : Snapshot of the Market Dynamics for Drug Discovery Technologies
Figure 2 : Most Frequent Cancer Types in Women, 2022
Figure 3 : Most Frequent Cancer Types in Men, 2022
Figure 4 : Share of Population Aged 65 and Older in G7 Countries, 2021
Figure 5 : Regional Shares of Population Aged 65+, 2016 and 2050
Figure 6 : Total Stem Cell Research Funding by the NIH, 2013–2024
Figure 7 : Process of Drug Discovery
Figure 8 : Global Market Shares of Drug Discovery Technologies, by Technology, 2023
Figure 9 : Global Market for HTS in Drug Discovery, by Region, 2021–2029
Figure 10 : Global Market for Bioanalytical Instruments in Drug Discovery, by Region, 2021–2029
Figure 11 : Global Market Shares of Genomics in Drug Discovery, by Region, 2023
Figure 12 : Global Market Shares of Proteomics in Drug Discovery, by Region, 2023
Figure 13 : Global Market Shares of Cell-based Assays and Reagents in Drug Discovery, by Region, 2023
Figure 14 : Global Market Shares of Bioinformatics in Drug Discovery, by Region, 2023
Figure 15 : Global Market Shares of Other Technologies in Drug Discovery, by Region, 2023
Figure 16 : Global Market Shares of Drug Discovery Technologies, by Application, 2023
Figure 17 : Global Market Shares of Drug Discovery Technologies in Oncology, by Region, 2023
Figure 18 : Global Market Shares of Drug Discovery Technologies in Cardiology, by Region, 2023
Figure 19 : Global Market Shares of Drug Discovery Technologies in Neurodegenerative Diseases, by Region, 2023
Figure 20 : Global Market Shares of Drug Discovery Technologies in Immunological Diseases, by Region, 2023
Figure 21 : Global Market Shares of Drug Discovery Technologies in Other Diseases, by Region, 2023
Figure 22 : Global Market Shares of Drug Discovery Technologies, by End User, 2023
Figure 23 : Global Market Shares of Drug Discovery Technologies in Biopharma Companies, by Region, 2023
Figure 24 : Global Market Shares of Drug Discovery Technologies in Research and Academia, by Region, 2023
Figure 25 : Global Market Shares of Drug Discovery Technologies in CROs, by Region, 2023
Figure 26 : Global Market for Drug Discovery Technologies, by Region, 2021–2029
Figure 27 : North American Market for Drug Discovery Technologies, by Product Type, 2021–2029
Figure 28 : North American Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 29 : North American Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 30 : North American Market Shares of Drug Discovery Technologies, by Country, 2023
Figure 31 : U.S. Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 32 : U.S. Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 33 : U.S. Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 34 : Canadian Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 35 : Canadian Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 36 : Canadian Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 37 : Mexican Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 38 : Mexican Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 39 : Mexican Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 40 : European Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 41 : European Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 42 : European Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 43 : European Market Shares of Drug Discovery Technologies, by Country, 2023
Figure 44 : German Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 45 : German Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 46 : German Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 47 : U.K. Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 48 : U.K. Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 49 : U.K. Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 50 : French Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 51 : French Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 52 : French Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 53 : Italian Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 54 : Italian Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 55 : Italian Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 56 : Spanish Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 57 : Spanish Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 58 : Spanish Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 59 : Rest of Europe Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 60 : Rest of Europe Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 61 : Rest of Europe Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 62 : Asia-Pacific Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 63 : Asia-Pacific Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 64 : Asia-Pacific Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 65 : Asia-Pacific Market Shares of Drug Discovery Technologies, by Country, 2023
Figure 66 : Chinese Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 67 : Chinese Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 68 : Chinese Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 69 : Japanese Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 70 : Japanese Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 71 : Japanese Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 72 : Indian Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 73 : Indian Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 74 : Indian Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 75 : South Korean Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 76 : South Korean Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 77 : South Korean Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 78 : Australian Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 79 : Australian Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 80 : Australian Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 81 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 82 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 83 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 84 : RoW Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 85 : RoW Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 86 : RoW Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 87 : RoW Market Shares of Drug Discovery Technologies, by Sub-Region, 2023
Figure 88 : South American Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 89 : South American Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 90 : South American Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 91 : MEA Market for Drug Discovery Technologies, by Technology, 2021–2029
Figure 92 : MEA Market for Drug Discovery Technologies, by Application, 2021–2029
Figure 93 : MEA Market for Drug Discovery Technologies, by End User, 2021–2029
Figure 94 : Global Market Shares of Drug Discovery Technologies, by Company, 2023
Figure 95 : SWOT Analysis of the Drug Discovery Technologies Market
Figure 96 : Pillars of ESG
Figure 97 : Benefits of ESG for Companies
Figure 98 : Global ESG-Adoption Level Across All Industries, 2021 and 2022
Figure 99 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 100 : Agilent Technologies Inc.: Revenue Share, by Region, FY 2023
Figure 101 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 102 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 103 : Bruker: Revenue Share, by Business Unit, FY 2023
Figure 104 : Bruker: Revenue Share, by Country/Region, FY 2023
Figure 105 : Charles River Laboratories: Revenue Share, by Business Unit, FY 2023
Figure 106 : Charles River Laboratories: Revenue Share, by Country/Region, FY 2023
Figure 107 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 108 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 109 : Illumina: Revenue Share, by Business Unit, FY 2023
Figure 110 : Illumina: Revenue Share, by Country/Region, FY 2023
Figure 111 : Qiagen: Market Share, by Business Unit, FY 2023
Figure 112 : Qiagen: Revenue Share, by Region, FY 2023
Figure 113 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 114 : Revvity: Revenue Share, by Region, FY 2023
Figure 115 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 116 : Thermo Fisher Scientific Inc.: Revenue Share, by Region, FY 2023

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 臓器チップ（Organ-on-a-Chip）の世界市場 2025-04-04
• シングルセルゲノミクスとプロテオミクスの新興技術と市場 2025-04-04
• 建物一体型太陽光発電（BIPV）の技術と世界市場 2025-04-04
• eコマース市場の地域別分析：中東および北アフリカ 2025-04-01
• アンテナ市場：種類（パッチアンテナ、埋め込み型アンテナ、フラクタルアンテナ、スマートアンテナ、反射鏡アンテナ）、最終用途、地域別2029年までの予測 2025-03-28

BCC Research  出版レポート一覧